semaglutide pink vs clear Victoza vs. Ozempic: A Comparison to Help You Decide TrimRX | Why Is My

A good provider will slow things down, look at labs, talk through risks and benefits in plain English, and tailor dosing to real goals instead of pushing everyone down the same path

Many compounding providers add these supplements to their formulations

Antioxidants (Basel, Switzerland), 12(4), Article 834

People with complex medical histories, pregnancy or breastfeeding considerations, diabetes medications, gastrointestinal disease, kidney disease, pancreatitis history, gallbladder concerns, or possible drug interactions should discuss risks with a licensed clinician

What FDA Requires for NASH Approval FDA NASH Drug Approval Criteria (Based on Past Trials): Option 1: Histological Improvement (Biopsy-Based) NASH resolution (no inflammation, no ballooning) AND no worsening of fibrosis OR Fibrosis improvement (1 stage reduction) AND no worsening of NASH Option 2: Surrogate Endpoints (If Validated) Combination of imaging + biomarkers Must correlate with clinical outcomes Requires extensive validation Retatrutide's Current Status: Phase 2a: Fat reduction proven (surrogate endpoint) Phase 3 (TRIUMPH): Liver enzymes being measured (secondary) Still needs: Dedicated NASH trial with liver biopsies Phase 3 TRIUMPH: What Liver Data Will We Get